Lucentis promising hopes for retinal vein occlusion in Phase III trial

6556611700324611Genentech, Inc. announced recently that the Phase III study BRAVO showed Lucentis (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion.

Full article »

Macular edema implant Ozurdex approved by FDA: Says Allergan Inc

Finally Food and Drug Administration(FDA) has given the permission to Allergen Inc. to sale its eye implant Ozurdex to treat macular edema.

Full article »

Optical ocular tomography - new coherent wave in ocular diagnosis

stratusoctThe advent of the most recent diagnostic technique using a coherent light waves promises to revolutionize eye condition study or detection. It is compared to that with the ultrasound sonography in some ways or the other but a small technical difference. In the later sound waves are utilised for detection while in case of Optical Ocular Tomography coherent light waves are used.

Full article »


Protected by Comment Guard Pro